CardioCytogen peptide (AEDR sequence) for cardiac tissue studies. Short peptides targeting fibroblast signal pathways. Laboratory research applications.
CardioCytogen is a synthetic tetrapeptide bioregulator composed of four amino acids (Ala-Glu-Asp-Arg). This short peptide demonstrates ability to modulate fibroblast activity and cardiomyocyte proliferation in cardiovascular research models.
Studies in rat tissue cultures show CardioCytogen can influence cardiac cell synthesis pathways and signal mechanisms related to tissue repair. The peptide targets specific cellular processes involved in cardiac remodeling and fibroblast regulation.
Research applications focus on understanding cardiovascular tissue dynamics and cellular proliferation mechanisms. For in vitro research use only.
Every Limitless Biotech compound undergoes independent testing for endotoxins and sterility, meeting rigorous research standards through our systematic quality protocols and proactive manufacturing processes.
Limitless Biotech provides USA-manufactured CardioCytogen for sale with verified molecular sequences and purity through comprehensive third-party testing. We ensure research quality with same-day shipping and dedicated customer support for your scientific endeavors.
At Limitless Biotech, we provide comprehensive Certificates of Analysis (COAs) for all of our research-only peptides to ensure transparency, purity, and quality in every batch. Each COA includes detailed analytical data that allows researchers to verify identity, concentration, and integrity, supporting reliable and reproducible scientific work. Our commitment to rigorous testing helps researchers move forward with confidence in the materials they use.
$6.99 - $14.29
$3.30
